New drug trial aims to tame Parkinson's and MSA
Disease control
Ongoing
This study tests a new medicine called exidavnemab in people with mild to moderate Parkinson's disease or multiple system atrophy (MSA). The main goal is to check if the drug is safe and tolerable. Participants will receive either the drug or a placebo, and researchers will monit…
Phase: PHASE2 • Sponsor: BioArctic AB • Aim: Disease control
Last updated May 13, 2026 15:59 UTC